bioMérieux S.A.

Paris Stock Exchange BIM.PA

bioMérieux S.A. Dividend Yield on January 14, 2025: 0.85%

bioMérieux S.A. Dividend Yield is 0.85% on January 14, 2025, a -1.86% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

bioMérieux S.A. 52-week high Dividend Yield is 0.98% on June 28, 2024, which is 16.43% above the current Dividend Yield.
bioMérieux S.A. 52-week low Dividend Yield is 0.77% on September 12, 2024, which is -9.22% below the current Dividend Yield.
bioMérieux S.A. average Dividend Yield for the last 52 weeks is 0.87%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

Paris Stock Exchange: BIM.PA

bioMérieux S.A.

CEO	Mr. Pierre Boulud
IPO Date	July 7, 2004
Location	France
Headquarters	376 Chemin De l'Orme
Employees	13,409
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Key trends

Past 5 years